DK1280795T3 - N-substituerede carbamoyloxyalkyl-azolium-derivater - Google Patents

N-substituerede carbamoyloxyalkyl-azolium-derivater

Info

Publication number
DK1280795T3
DK1280795T3 DK00992946T DK00992946T DK1280795T3 DK 1280795 T3 DK1280795 T3 DK 1280795T3 DK 00992946 T DK00992946 T DK 00992946T DK 00992946 T DK00992946 T DK 00992946T DK 1280795 T3 DK1280795 T3 DK 1280795T3
Authority
DK
Denmark
Prior art keywords
azolium
derivatives
carbamoyloxyalkyl
substituted
substituted carbamoyloxyalkyl
Prior art date
Application number
DK00992946T
Other languages
English (en)
Inventor
Hiroshi Fukuda
Tadakatsu Nippon Roche Hayase
Eisaku Mizuguchi
Nobuo Shimma
Jun Ohwada
Nobuhiro Carlton Pla Ka Oikawa
Masahiro Puranbehru Sakaitani
Masao Tsukazaki
Isao Imp Higashi Hakurak Umeda
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Application granted granted Critical
Publication of DK1280795T3 publication Critical patent/DK1280795T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00992946T 1999-11-02 2000-10-25 N-substituerede carbamoyloxyalkyl-azolium-derivater DK1280795T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99121694 1999-11-02
EP00992946A EP1280795B1 (en) 1999-11-02 2000-10-25 N-substituted carbamoyloxyalkyl-azolium derivatives
PCT/EP2000/010524 WO2001032652A2 (en) 1999-11-02 2000-10-25 N-substituted carbamoyloxyalkyl-azolium derivatives

Publications (1)

Publication Number Publication Date
DK1280795T3 true DK1280795T3 (da) 2005-07-18

Family

ID=8239312

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00992946T DK1280795T3 (da) 1999-11-02 2000-10-25 N-substituerede carbamoyloxyalkyl-azolium-derivater

Country Status (22)

Country Link
EP (1) EP1280795B1 (da)
JP (1) JP3787307B2 (da)
KR (1) KR100449797B1 (da)
CN (1) CN1185230C (da)
AR (1) AR029403A1 (da)
AT (1) ATE291575T1 (da)
AU (1) AU777859B2 (da)
BE (1) BE2016C007I2 (da)
BR (1) BRPI0015254C1 (da)
CA (2) CA2680292C (da)
CY (1) CY2016002I2 (da)
DE (1) DE60018989T2 (da)
DK (1) DK1280795T3 (da)
ES (1) ES2238341T3 (da)
FR (1) FR15C0096I2 (da)
LU (1) LU92939I2 (da)
MX (1) MXPA02004145A (da)
NL (1) NL300791I2 (da)
PT (1) PT1280795E (da)
TR (1) TR200201205T2 (da)
WO (1) WO2001032652A2 (da)
ZA (1) ZA200203003B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
EP2192893B1 (en) 2007-08-21 2015-08-19 Basilea Pharmaceutica AG Antifungal composition
CA2840215A1 (en) 2011-06-22 2012-12-27 Abhijit S. BAPAT Conjugate-based antifungal and antibacterial prodrugs
AU2014276460A1 (en) 2013-06-04 2015-12-24 Vyome Biosciences Pvt. Ltd. Coated particles and compositions comprising same
CN104230894B (zh) * 2013-06-06 2016-08-24 南京华威医药科技开发有限公司 三唑类化合物
CA2972401C (en) * 2014-12-30 2023-09-05 Dow Agrosciences Llc Picolinamide compounds with fungicidal activity
CN106032356B (zh) * 2015-03-13 2018-09-14 江苏正大丰海制药有限公司 一种[n-甲基-吡啶-2-基]氨基甲酸-1-氯乙酯的制备方法
CN104974143A (zh) * 2015-05-12 2015-10-14 深圳致君制药有限公司 一种季铵盐类化合物、其制备方法以及用途
CN106467519B (zh) * 2015-08-17 2019-08-13 南京华威医药科技集团有限公司 一种水溶性三唑化合物
CN106467534B (zh) * 2015-08-17 2019-10-11 江苏奥赛康药业有限公司 一种硫酸艾沙康唑鎓化合物及其药物组合物
CN106565699B (zh) * 2015-10-10 2019-07-26 江苏正大丰海制药有限公司 一种艾沙康唑硫酸盐晶体及其制备方法
WO2018067702A1 (en) 2016-10-04 2018-04-12 Massachusetts Institute Of Technology Bottlebrush copolymers and uses thereof
EP3584245A4 (en) 2017-02-17 2020-08-26 Wuhan LL Science And Technology Development Co., Ltd. TRIAZOLE ANTIBACTERIAL DERIVATIVE, ASSOCIATED PHARMACEUTICAL COMPOSITION AND USE
CN106916152B (zh) * 2017-04-27 2019-09-17 扬子江药业集团有限公司 氧化还原反应制备艾沙康唑鎓单硫酸盐的方法
US10716858B2 (en) 2017-06-30 2020-07-21 Massachusetts Institute Of Technology Branched multi-functional macromonomers and uses thereof
US11752221B2 (en) 2017-06-30 2023-09-12 Massachusetts Institute Of Technology Brush-arm star polymer imaging agents and uses thereof
US10368502B2 (en) 2017-09-25 2019-08-06 Multiple Energy Technologies Llc Bioceramic and carbon-based hydroponic systems, methods and devices
CN110317165A (zh) * 2018-03-28 2019-10-11 上海医药工业研究院 一种药物中间体2-甲胺基-3-吡啶甲醇的制备方法
CN110551064B (zh) * 2018-06-01 2021-01-01 重庆世森医药科技有限公司 艾沙康唑硫酸酯及其中间体的制备方法
MX2021001116A (es) 2018-08-01 2021-03-31 Basilea Pharm Int Ag Metodos para purificar sulfato de isavuconazonio.
WO2020037236A1 (en) 2018-08-17 2020-02-20 Massachusetts Institute Of Technology Degradable polymers of a cyclic silyl ether and uses thereof
CN110128420A (zh) * 2019-05-08 2019-08-16 阴启明 硫酸氢根/硫酸根型阴离子交换技术制备艾沙康唑鎓单硫酸盐的方法
EP4021576A1 (en) 2019-08-26 2022-07-06 Synthon B.V. Isavuconazonium salts and process for preparing thereof
KR20220085791A (ko) * 2019-10-16 2022-06-22 메사추세츠 인스티튜트 오브 테크놀로지 브러시 전구약물 및 그의 용도
JP2023049010A (ja) 2021-09-28 2023-04-07 旭化成ファーマ株式会社 エアベント付き輸液フィルタを備える点滴静脈投与用輸液セット
JP7454905B2 (ja) 2021-09-28 2024-03-25 旭化成ファーマ株式会社 有効成分であるイサブコナゾール又はそのプロドラッグを含有する真菌症治療及び/又は予防剤
EP4289840A1 (en) 2022-06-07 2023-12-13 Zaklady Farmaceutyczne Polpharma S.A. A process for preparing isavuconazonium sulfate
WO2024094329A1 (en) 2022-11-01 2024-05-10 Basilea Pharmaceutica International Ag, Allschwil Blister-packaged capsule preparation containing isavuconazonium sulfate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3108997B2 (ja) * 1997-03-31 2000-11-13 武田薬品工業株式会社 アゾール化合物、その製造法および用途
CA2281875A1 (en) * 1997-03-31 1998-10-08 Takeda Chemical Industries, Ltd. Azole compounds, their production and their use
WO1999045008A1 (en) * 1998-03-06 1999-09-10 F. Hoffmann-La Roche Ag 3-[4-(4-cyanophenyl)thiazol-2-y)]-1-(1h-1,2,4-triazol-1-yl)-butan-2-ol derivatives having antifungal activity

Also Published As

Publication number Publication date
BRPI0015254C1 (pt) 2021-05-25
MXPA02004145A (es) 2002-10-17
PT1280795E (pt) 2005-06-30
WO2001032652A3 (en) 2001-11-15
AR029403A1 (es) 2003-06-25
CA2388320A1 (en) 2001-05-10
CA2388320C (en) 2009-12-15
JP3787307B2 (ja) 2006-06-21
FR15C0096I2 (fr) 2016-04-22
CY2016002I1 (el) 2016-10-05
CY2016002I2 (el) 2016-10-05
DE60018989D1 (de) 2005-04-28
CN1185230C (zh) 2005-01-19
CA2680292C (en) 2012-11-27
TR200201205T2 (tr) 2002-08-21
JP2003513090A (ja) 2003-04-08
FR15C0096I1 (da) 2016-02-12
NL300791I1 (da) 2016-03-15
BE2016C007I2 (da) 2019-10-23
BR0015254A (pt) 2002-06-25
ZA200203003B (en) 2003-09-23
EP1280795A2 (en) 2003-02-05
KR20020062298A (ko) 2002-07-25
NL300791I2 (da) 2016-03-15
AU777859B2 (en) 2004-11-04
BR0015254B1 (pt) 2013-05-21
CA2680292A1 (en) 2001-05-10
AU2835201A (en) 2001-05-14
WO2001032652A2 (en) 2001-05-10
KR100449797B1 (ko) 2004-09-30
CN1387529A (zh) 2002-12-25
EP1280795B1 (en) 2005-03-23
LU92939I2 (fr) 2016-03-07
BRPI0015254B8 (pt) 2017-04-25
ES2238341T9 (es) 2016-03-02
ATE291575T1 (de) 2005-04-15
DE60018989T2 (de) 2005-08-18
ES2238341T3 (es) 2005-09-01

Similar Documents

Publication Publication Date Title
CY2016002I2 (el) Ν-υποκατεστημενο καρβαμουλοξυαλκυλιο - παραγωγα αζολιου
DK1163237T3 (da) Amidderivater
NO20000885D0 (no) 4-Fenyl-pyridin-derivater
NO20021077L (no) Amino-triazolopyridin-derivater
DE60009747D1 (de) Admantan-derivate
DE50010060D1 (de) Thiazolylamid-derivate
IS6128A (is) 13-Metýl-erýþrómýsín afleiður
DK1187814T3 (da) 5-phenyl-pyrimidinderivater
NO20021803D0 (no) Isoksazolkarboksamid-derivater
ATE257148T1 (de) Propargyletherderivate
DK1154988T3 (da) Mevinolinderivater
ATE374747T1 (de) Monofluoralkylderivate
DK1187815T3 (da) 4-phenyl-pyrimidinderivater
DE60006703D1 (de) 4-hydroxybiphenylhydrazid-derivate
ATE293592T1 (de) Resorcinderivate
NO20020212D0 (no) 3-amino-2-benzyl-1-fenyl-propanderivater
NO20022867D0 (no) Syklopentenon-derivater
DK1189886T3 (da) Ethansulfonyl-piperidinderivater
DE60001736D1 (de) 1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate
DE50003014D1 (de) N-substituierte perhydrodiazine
DE59909774D1 (de) 1-cycloalkylpyrazolyl-benzoyl-derivate
NO20021310D0 (no) Aminderivater